Nektar Therapeutics
NKTR
#6053
Rank
HK$8.09 B
Marketcap
HK$236.71
Share price
-7.19%
Change (1 day)
-49.63%
Change (1 year)

EPS for Nektar Therapeutics (NKTR)

EPS in 2026 (TTM): -HK$52.31

According to Nektar Therapeutics 's latest financial reports the company's current EPS (TTM) is -HK$52.52. In 2025 the company made an earnings per share (EPS) of -HK$79.95 a decrease over its 2024 EPS that were of -HK$69.45.

EPS history for Nektar Therapeutics from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-HK$52.31-34.57%
2025-HK$79.9515.12%
2024-HK$69.45-59.54%
2023-HK$171.66-25.89%
2022-HK$231.62-31.12%
2021-HK$336.2614.86%
2020-HK$292.75-1.19%
2019-HK$296.28-163.96%
2018HK$463.23-725.4%
2017-HK$74.07-42.73%
2016-HK$129.3383.33%
2015-HK$70.5439.53%
2014-HK$50.56-69.29%
2013-HK$164.60-6.67%
2012-HK$176.36

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
HK$52.36-199.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
HK$5.57-110.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$136.23-359.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
-HK$11.05-78.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$7.78-114.82%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
HK$55.81-206.27%๐Ÿ‡ฌ๐Ÿ‡ง UK
Richardson Electronics
RELL
HK$4.70-108.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Alkermes
ALKS
-HK$0.0000000000-100.00%๐Ÿ‡ฎ๐Ÿ‡ช Ireland